Personal and social performance in schizophrenia: double-blind, non-inferiority study of once-monthly vs oral aripiprazole

被引：1
|
作者：
Fleischhacker, W. W. [1 ]
Sanchez, R. [2 ]
Jin, N. [3 ]
Peters-Strickland, T. [2 ]
Johnson, B. R. [4 ]
Eramo, A. [5 ]
Loze, J. Y. [6 ]
McQuade, R. D. [7 ]
Carson, W. H. [8 ]
Kane, J. [9 ,10 ]
机构：
[1] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Global Clin Dev CNS, Princeton, NJ USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Biostat, Rockville, MD USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[5] H Lundbeck & Co AS, Med Affairs & Phase Clin Affairs 4, Deerfield, IL USA
[6] Otsuka Pharmaceut Europe Ltd, European CNS Market Access, London, England
[7] Otsuka Pharmaceut Dev & Commercializat Inc, Global Med Regulatory Affairs & Alliances, Princeton, NJ USA
[8] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[9] Zucker Hillside Hosp, Glen Oaks, NY USA
[10] Hofstra North Shore LIJ Sch Med, Dept Psychiat, Glen Oaks, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70751-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.028
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [31] Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia
    Naber, Dieter
    Hansen, Karina
    Forray, Carlos
    Baker, Ross A.
    Sapin, Christophe
    Beillat, Maud
    Peters-Strickland, Timothy
    Nylander, Anna-Greta
    Hertel, Peter
    Andersen, Henrik Steen
    Eramo, Anna
    Loze, Jean-Yves
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 498 - 504
  • [32] Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
    Oloruntoba Oluboka
    Guerline Clerzius
    Wolfgang Janetzky
    Daniel Schöttle
    François Therrien
    Klaus Wiedemann
    Marc-André Roy
    BMC Psychiatry, 23
  • [33] FUNCTIONAL OUTCOMES WITH ARIPIPRAZOLE ONCE-MONTHLY IN TWO DOUBLE-BLIND, PLACEBO-AND ACTIVE-CONTROLLED STUDIES (ASPIRE US 246 AND ASPIRE EU 247) FOR THE TREATMENT OF SCHIZOPHRENIA
    Fleischhacker, W. W.
    Perry, P.
    Sanchez, R.
    Jin, N.
    Peters-Strickland, T.
    Johnson, B.
    Baker, R.
    Eramo, A.
    McQuade, R. D.
    Carson, W. H.
    Kane, J. M.
    VALUE IN HEALTH, 2013, 16 (07) : A550 - A550
  • [34] Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
    Oluboka, Oloruntoba
    Clerzius, Guerline
    Janetzky, Wolfgang
    Schoettle, Daniel
    Therrien, Francois
    Wiedemann, Klaus
    Roy, Marc-Andre
    BMC PSYCHIATRY, 2023, 23 (01)
  • [35] Aripiprazole once-monthly maintenance treatment of bipolar I disorder, a double-blind, placebo-controlled, randomized withdrawal study: effects on types of recurrence and on recovery
    Calabrese, J.
    Sanchez, R.
    Jin, N.
    Amatniek, J.
    Cox, K.
    Johnson, B.
    Perry, P. P.
    Hertel, P.
    Such, P.
    McQuade, R. D.
    Nyilas, M.
    Carson, W. H.
    BIPOLAR DISORDERS, 2017, 19 : 136 - 136
  • [36] ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA IN OBESE AND NON-OBESE PATIENTS; A POST-HOC ANALYSIS
    De Hert, M.
    Eramo, A.
    Landsberg, W.
    Tsai, L. F.
    Kostic, D.
    Baker, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [37] Aipiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis
    Kishi, Taro
    Sakuma, Kenji
    Iwata, Nakao
    PHARMACOPSYCHIATRY, 2022, 55 (06) : 291 - 296
  • [38] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study (vol 18, 365, 2018)
    Schoettle, Daniel
    Janetzky, Wolfgang
    Luedecke, Daniel
    Beck, Elmar
    Correll, Christoph U.
    Wiedemann, Klaus
    BMC PSYCHIATRY, 2018, 18
  • [39] Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study
    Calabrese, Joseph R.
    Sanchez, Raymond
    Jin, Na
    Amatniek, Joan
    Cox, Kevin
    Johnson, Brian
    Perry, Pamela
    Hertel, Peter
    Such, Pedro
    Salzman, Phyllis M.
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (03) : 324 - +
  • [40] Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
    Javaud, Nicolas
    Soria, Angele
    Maignan, Maxime
    Martin, Ludovic
    Descamps, Vincent
    Fain, Olivier
    Bouillet, Laurence
    Berard, Frederic
    Tazarourte, Karim
    Roy, Pierre-Marie
    Fontaine, Jean-Paul
    Bagot, Martine
    Khellaf, Mehdi
    Goulet, Helene
    Lapostolle, Frederic
    Casalino, Enrique
    Doutre, Marie-Sylvie
    Gil-Jardine, Cedric
    Caux, Frederic
    Chosidow, Olivier
    Pateron, Dominique
    Vicaut, Eric
    Adnet, Frederic
    BMJ OPEN, 2019, 9 (08):
12345